Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Hauser

Showing results (221-230 of 419) with videos related to

Pageof 42
Sort By:
Neurology|May 1, 1993
Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment GroupH L Weiner, G A Mackin, E J Orav, et al.
Science Advances|November 25, 2015
Crowdsourced earthquake early warningSarah E Minson, Benjamin A Brooks, Craig L Glennie, et al.
Journal of Magnetic Resonance Imaging : JMRI|December 9, 2014
2D phase-sensitive inversion recovery imaging to measure in vivo spinal cord gray and white matter areas in clinically feasible acquisition timesNico Papinutto, Regina Schlaeger, Valentina Panara, et al.
Human Immunology|September 15, 1996
Tumor necrosis factor (TNF) microsatellite haplotypes in relation to extended haplotypes, susceptibility to diseases associated with the major histocompatibility complex and TNF secretionA Garcia-Merino, C A Alper, K Usuku, et al.
Annals of Neurology|May 4, 2010
Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?Amit Bar-Or, Lama Fawaz, Boli Fan, et al.
Journal of Neurology|December 5, 2022
Neural correlates of digital measures shown by structural MRI: a post-hoc analysis of a smartphone-based remote assessment feasibility study in multiple sclerosisMarco Ganzetti, Jennifer S Graves, Sven P Holm, et al.
Multiple Sclerosis and Related Disorders|December 11, 2025
Six-year safety and efficacy outcomes with first-line ofatumumab in recently diagnosed treatment-naive patients with relapsing multiple sclerosisStephen L Hauser, Mark S Freedman, Jin Nakahara, et al.
European Journal of Neurology|July 24, 2023
Progressive multifocal leukoencephalopathy in a patient with relapsing multiple sclerosis treated with ocrelizumab: A case reportMarc Puig-Casadevall, Gary Álvarez-Bravo, Ana Quiroga Varela, et al.
Environmental Science & Technology|June 2, 2005
A predictive approach to nutrient criteriaK H Reckhow, G B Arhonditsis, M A Kenney, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 30, 2017
SUMMIT (Serially Unified Multicenter Multiple Sclerosis Investigation): creating a repository of deeply phenotyped contemporary multiple sclerosis cohortsRiley Bove, Tanuja Chitnis, Bruce Ac Cree, et al.
Pageof 42

Showing results (221-230 of 419) with videos related to

Sort By:
Pageof 42
Neurology|May 1, 1993
Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment GroupH L Weiner, G A Mackin, E J Orav, et al.
Science Advances|November 25, 2015
Crowdsourced earthquake early warningSarah E Minson, Benjamin A Brooks, Craig L Glennie, et al.
Journal of Magnetic Resonance Imaging : JMRI|December 9, 2014
2D phase-sensitive inversion recovery imaging to measure in vivo spinal cord gray and white matter areas in clinically feasible acquisition timesNico Papinutto, Regina Schlaeger, Valentina Panara, et al.
Human Immunology|September 15, 1996
Tumor necrosis factor (TNF) microsatellite haplotypes in relation to extended haplotypes, susceptibility to diseases associated with the major histocompatibility complex and TNF secretionA Garcia-Merino, C A Alper, K Usuku, et al.
Annals of Neurology|May 4, 2010
Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?Amit Bar-Or, Lama Fawaz, Boli Fan, et al.
Journal of Neurology|December 5, 2022
Neural correlates of digital measures shown by structural MRI: a post-hoc analysis of a smartphone-based remote assessment feasibility study in multiple sclerosisMarco Ganzetti, Jennifer S Graves, Sven P Holm, et al.
Multiple Sclerosis and Related Disorders|December 11, 2025
Six-year safety and efficacy outcomes with first-line ofatumumab in recently diagnosed treatment-naive patients with relapsing multiple sclerosisStephen L Hauser, Mark S Freedman, Jin Nakahara, et al.
European Journal of Neurology|July 24, 2023
Progressive multifocal leukoencephalopathy in a patient with relapsing multiple sclerosis treated with ocrelizumab: A case reportMarc Puig-Casadevall, Gary Álvarez-Bravo, Ana Quiroga Varela, et al.
Environmental Science & Technology|June 2, 2005
A predictive approach to nutrient criteriaK H Reckhow, G B Arhonditsis, M A Kenney, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 30, 2017
SUMMIT (Serially Unified Multicenter Multiple Sclerosis Investigation): creating a repository of deeply phenotyped contemporary multiple sclerosis cohortsRiley Bove, Tanuja Chitnis, Bruce Ac Cree, et al.
Pageof 42